1. Home
  2. SONM vs AYTU Comparison

SONM vs AYTU Comparison

Compare SONM & AYTU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sonim Technologies Inc.

SONM

Sonim Technologies Inc.

HOLD

Current Price

$5.96

Market Cap

6.5M

ML Signal

HOLD

Logo Aytu BioPharma Inc.

AYTU

Aytu BioPharma Inc.

HOLD

Current Price

$2.58

Market Cap

23.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SONM
AYTU
Founded
1999
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.5M
23.4M
IPO Year
2019
N/A

Fundamental Metrics

Financial Performance
Metric
SONM
AYTU
Price
$5.96
$2.58
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$9.33
AVG Volume (30 Days)
39.7K
82.2K
Earning Date
10-31-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$59,109,000.00
$63,696,000.00
Revenue This Year
$127.68
N/A
Revenue Next Year
N/A
$47.30
P/E Ratio
N/A
N/A
Revenue Growth
4.17
N/A
52 Week Low
$4.75
$0.95
52 Week High
$114.84
$2.82

Technical Indicators

Market Signals
Indicator
SONM
AYTU
Relative Strength Index (RSI) 44.94 69.48
Support Level $4.93 $2.05
Resistance Level $6.86 $2.67
Average True Range (ATR) 0.50 0.13
MACD -0.09 0.04
Stochastic Oscillator 42.99 85.48

Price Performance

Historical Comparison
SONM
AYTU

About SONM Sonim Technologies Inc.

Sonim Technologies Inc is a provider of ultra-rugged mobile devices, including phones and accessories designed specifically for task workers physically engaged in their work environments, often in mission-critical roles. The company sells mobile phones, accessories, and solutions to AT&T, T-Mobile, and Verizon in the Canada, and to Bell, Rogers, and Telus and Rogers, Telstra in Australia. The products include rugged mobile phones that can attach to both public and private wireless networks, industrial-grade accessories that meet the requirements of specific applications and software applications, and cloud-based tools that provide management and deployment services to customers. The company generates revenue from discounts, price protection, and customer incentives.

About AYTU Aytu BioPharma Inc.

Aytu BioPharma Inc is a specialty pharmaceutical company with a commercial portfolio of prescription therapeutics and consumer health products. The company's primary prescription products treat attention deficit hyperactivity disorder and other common pediatric conditions. It is building a complementary therapeutic development pipeline, including a prospective treatment (AR101/enzastaurin) for vascular Ehlers-Danlos Syndrome, a rare genetic disease resulting in high morbidity and a significantly shortened lifespan. The company operates one business segment consisting of various prescription pharmaceutical products sold through third parties.

Share on Social Networks: